6 Reasons Why AGP Could Rise to PKR 265 Soon
6: Declining Finance Costs Will Lift Net Profitability
Leverage Is Turning Into an Earnings Tailwind
AGP carries relatively high leverage, but this is now working in its favor as interest rates decline.
As of September 2025:
📢 Announcement: You can now access our services and similar analyses by opening an account with us via JS Global

Â
- Debt to equity stood at 0.75 times
- Debt to assets stood at 0.33 times
The company is gradually retiring long term borrowings.
Net Margins Are Expected to Expand
Net margins are expected to improve by up to 17 percent over the next three years, driven primarily by lower finance costs.
Earnings Outlook
| Metric | CY25E | CY26F | CY27F |
|---|---|---|---|
| Sales Rs mn | 28,820 | 33,558 | 37,772 |
| PAT Rs mn | 3,943 | 4,826 | 5,742 |
| EPS Rs | 14.08 | 17.24 | 20.51 |
| DPS Rs | 6.00 | 7.25 | 8.50 |
Valuation Supports Further Upside
AGP is trading at an estimated CY26 price to earnings multiple of around 11.8 times. Given its superior margins, volume driven growth, and improving profitability, this valuation leaves room for re rating.
📢 Announcement: We're on WhatsApp – Join Us There!Â
Â
Â
At PKR 265, the stock also offers a dividend yield of approximately 4 percent.
What Are Analysts Saying About AGP Stock?
According to the KSEStocks Database, AGP is covered by 7 analysts in Pakistan and they have an average price rating of PKR 268. This average price target suggests an upside of 18.3% from the last close of PKR 226.99.
According to EPS estimates from 7 different brokers, AGP has an average 2026 EPS expectation of 16.7. This suggests the stock is now trading at a forward PE of 13.7.
Here is how the current AGP EPS estimates look like:
| Symbol | Research | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | Last Updated | Fwd P/E 2026 | Fwd P/E 2027 | Fwd P/E 2028 | Fwd P/E 2029 | Fwd P/E 2030 | Last Close |
| AGP | IGI | 11.8 | 15 | 19.3 | 15/12/2025 | 15.1 | 11.8 | 226.99 | |||||||
| AGP | Intermarket | 16.64 | 19.63 | 01/01/2026 | 13.6 | 11.6 | 226.99 | ||||||||
| AGP | JS | 14.08 | 17.24 | 20.51 | 01/01/2026 | 13.2 | 11.1 | 226.99 | |||||||
| AGP | MMK | 10.57 | 14.06 | 17.37 | 23.21 | 15/01/2026 | 13.1 | 9.8 | 226.99 | ||||||
| AGP | Optimus | 13.5 | 15.9 | 18.2 | 01/01/2026 | 14.3 | 12.5 | 226.99 | |||||||
| AGP | Spectrum | 9.53 | 12 | 14.6 | 01/01/2026 | 15.5 | 226.99 | ||||||||
| AGP | Taurus | 14.3 | 19.9 | 23.2 | 01/12/2025 | 11.4 | 9.8 | 226.99 |
Here is how the current AGP Dividend estimates look like:
| Symbol | Research | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | Last Updated | Fwd Div Yield 2026 | Fwd Div Yield 2027 | Fwd Div Yield 2028 | Fwd Div Yield 2029 | Fwd Div Yield 2030 | Last Close |
| AGP | IGI | 5.8 | 7.5 | 9.8 | 15/12/2025 | 3.3 | 4.3 | 226.99 | |||||||
| AGP | Intermarket | 5 | 6 | 01/01/2026 | 2.2 | 2.6 | 226.99 | ||||||||
| AGP | JS | 6 | 7.25 | 8.75 | 01/01/2026 | 3.2 | 3.9 | 226.99 | |||||||
| AGP | MMK | 4 | 5.63 | 6.95 | 9.28 | 15/01/2026 | 3.1 | 4.1 | 226.99 | ||||||
| AGP | Optimus | 6 | 7 | 8 | 01/01/2026 | 3.1 | 3.5 | 226.99 | |||||||
| AGP | Spectrum | 4 | 4 | 4 | 01/01/2026 | 1.8 | 226.99 | ||||||||
| AGP | Taurus | 5 | 8 | 9 | 01/12/2025 | 3.5 | 4.0 | 226.99 |
Why do we compile research firms’ forecasts? Broker research is fragmented across different houses. Compiling it in one place helps investors see consensus, identify divergence, and think independently rather than relying on a single view.
Conclusion
AGP’s investment case is built on execution and structural improvements within the business.
Strong margins, rising volumes, a favorable product mix, growing exposure to chronic therapies, expanding exports, and falling finance costs together create a clear pathway for earnings growth. These company specific factors support the case for AGP moving toward PKR 265 in the near term.
⚠️ This post reflects the author’s personal opinion and is for informational purposes only. It does not constitute financial advice. Investing involves risk and should be done independently. Read full disclaimer →


Leave a Reply